PL EN
 
5/2009 vol. 63
Get citation
Nosicielstwo allela A polimorfizmu – 455G>A genu fibrynogenu beta zwiększa ryzyko choroby wieńcowej przy jednoczesnym podwyższonym stężeniu triglicerydów w surowicy
Beata Sarecka-Hujar 1
,
 
Iwona Zak 1
,
 
Jolanta Krauze 2
 
 
 
More details
Hide details
1
Department of Biochemistry and Medical Genetics, School of Health Care, Medical University of Silesia, Katowice, Poland
 
2
The First Department of Cardiac Surgery, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
 
 
Corresponding author
Beata Sarecka-Hujar   

Department of Biochemistry and Medical Genetics, School of Health Care Medical University of Silesia, Kasztanowa Str. 3, 41-200 Sosnowiec, Poland; phone: (+48 32) 269 98 20
 
 
Ann. Acad. Med. Siles. 2009;63:41-49
 
Article (PDF, 153.46 kB)
References (36)
 
KEYWORDS
Coronary artery disease
gene polymorphism
fi brinogen beta
lipids
traditional risk factors
 
ABSTRACT
Background:
Fibrinogen promotes development of atherosclerosis by directed integration in atherosclerotic lesions where it is converted into fi brin. The aim of the study was to assess a relationship between –455G>A polymorphism of beta fi brinogen (FGB) gene and coronary artery disease (CAD) in the Polish patients from Upper Silesia region and to establish whether there are any interactions between this polymorphism and traditional risk factors that infl uence the risk of CAD.

Material and Methods:
We analyzed 191 patients with angiographically documented CAD and 203 blood donors. Genetic analysis was performed using PCR-RFLP method.

Results:
The frequency of FGB -455G>A genotypes was compatible with HardyWeinberg equilibrium. There was no significant differences in the distribution of A allele and A allele carriers of FGB polymorphism between cases and controls. We observed a tendency to higher level of plasma fibrinogen in subjects with AA or GA genotypes than in GG homozygotes. We also found strong synergistic effects between A allele carrier-state and increased level of triacylglycerols (TG) in determining the risk of CAD (SI=5.97, SIM=2.63). Carriers of A allele with elevated level of TG were 3-fold more frequent among cases than in control group (12.0% vs 3.9%, p=0.003,OR=3.34).

Conclusions:
There is a synergistic effect between –455G>A polymorphism of FGB gene and elevated concentration of serum triacylglycerols which determine the risk of CAD.
REFERENCES (36)
1.
Chung D.W., Harris J.E., Davie E.W. Nucleotide sequences of the three genes coding for human fi brinogen. Adv. Exp. Med. Biol. 1990; 281: 39-48.
Google Scholar
 
 
2.
Zhang J.Z., Redman C.M. Identifi cation of B beta chain domains involved in human fi brinogen assembly. J. Biol. Chem. 1992; 267: 21727-21732.
Google Scholar
 
 
3.
Bazzano L.A., He J., Muntner P., Vupputuri S., Whelton P.K. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann. Intern. Med. 2003; 138: 891-897.
Google Scholar
 
 
4.
Thomas A.E., Green F.R., Kelleher C.H. i wsp. Variation in the promoter region of the beta fi brinogen gene is associated with plasma fi brinogen levels in smokers and non-smokers. Thromb. Haemost. 1991; 65:487-490.
Google Scholar
 
 
5.
Tybjaerg-Hansen A., Agerholm-Larsen B., Humphries S.E., Abildgaard S., Schnohr P., Nordestgaard B.G. A common mutation (G-455--> A) in the beta-fi brinogen promoter is an independent predictor of plasma fi brinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. J. Clin. Invest. 1997; 99: 3034- 3039.
Google Scholar
 
 
6.
Smith E.B., Keen G.A., Grant A., Stirk C. Fate of fi brinogen in human arterial intima. Arteriosclerosis 1990; 10:263-275.
Google Scholar
 
 
7.
Lindsberg P.J., Grau A.J. Infl ammation and infections as risk factors for ischemic stroke. Stroke 2003; 34: 2518-2532.
Google Scholar
 
 
8.
Behague I., Poirier O., Nicaud V. i wsp. Beta fi brinogen gene polymorphisms are associated with plasma fi brinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l‘Infarctus du Myocarde. Circulation 1996; 93: 440-449.
Google Scholar
 
 
9.
Hamsten A., Iselius L., de Faire U., Blomback M. Genetic and cultural inheritance of plasma fi brinogen concentration. Lancet 1987; 2: 988-991.
Google Scholar
 
 
10.
Dalmon J., Laurent M., Courtois G. The human beta fi brinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol. Cell Biol. 1993; 13: 1183-1193.
Google Scholar
 
 
11.
Judkin M.P., Gander M.P. Prevention of complications of coronary arteriography. Circulation 1974; 49: 599-602.
Google Scholar
 
 
12.
Alpert J.S., Thygesen K. Myocardial infarction redefi ned – A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefi nition of Myocardial Infarction. Eur. Heart J. 2000; 21: 1502-1513.
Google Scholar
 
 
13.
Sarecka-Hujar B., Zak I., Krauze J. Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors infl uence susceptibility to coronary artery disease. Clin. Exp. Med. 2009; 9:117-124.
Google Scholar
 
 
14.
Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of preparative centrifuge. Clin. Chem. 1972; 18: 499- 502.
Google Scholar
 
 
15.
Nishiuma S., Kario K., Yakushijin K. i wsp. Genetic variation in the promoter region of the beta-fi brinogen gene is associated with ischemic stroke in a Japanese population. Blood Coagul. Fibrinolysis 1998; 9:373-379.
Google Scholar
 
 
16.
Rothman K.J. Synergy and antagonism in cause-eff ect relationship. Am. J. Epidemiol. 1974; 99: 385-388.
Google Scholar
 
 
17.
Khoury M.J., Flanders W.D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am. J. Epidemiol. 1996; 144: 207-213.
Google Scholar
 
 
18.
Lam K.S., Ma O.C., Wat N.M., Chan L.C., Janus E.D. Beta-fi brinogen gene G/A-455 polymorphism in relation to fi brinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes. Diabetologia 1999; 42: 1250-1253.
Google Scholar
 
 
19.
de Maat M.P., Kastelein J.J., Jukema J.W. i wsp. -455G/A polymorphism of the beta-fi brinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: proposed role for an acute-phase reaction pattern of fi brinogen. REGRESS group. Arterioscler. Thromb. Vasc. Biol. 1998; 18: 265-271.
Google Scholar
 
 
20.
Bi S., Wang D., Li G., Wen S., Pan S. Beta-fi brinogen promoter -455 G/A (HaeIII) polymorphism prediction of plasma fi brinogen but not of ischemic cerebrovascular disease. Chin. Med. Sci. J. 2004; 19: 1-5.
Google Scholar
 
 
21.
Ando R., Doi M., Yamauchi K. i wsp. Association of beta-fi brinogen and factor VII polymorphism with plasma fi brinogen and factor VII levels, and no association of PAI-1 polymorphism with plasma PAI-1 levels in hemodialysis patients. Clin. Nephrol. 2002; 58: 25-32.
Google Scholar
 
 
22.
Lee A.J., Fowkes F.G., Lowe G.D., Connor J.M., Rumley A. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study. Thromb. Haemost. 1999; 81: 553-560.
Google Scholar
 
 
23.
de Maat M.P., de Knijff P., Green F.R., Thomas A.E., Jespersen J., Kluft C. Genderrelated association between beta-fi brinogen genotype and plasma fi brinogen levels and linkage disequilibrium at the fi brinogen locus in Greenland Inuit. Arterioscler. Thromb. Vasc. Biol. 1995; 15: 856-860.
Google Scholar
 
 
24.
Thomas A., Lamlum H., Humphries S., Green F. Linkage disequilibrium across the fi brinogen locus as shown by fi ve genetic polymorphisms, G/A-455 (HaeIII), C/T- 148 (HindIII/AluI), T/G+1689 (AvaII), and BclI (beta-fi brinogen) and TaqI (alphafi brinogen), and their detection by PCR. Hum. Mutat. 1994; 3: 79-81.
Google Scholar
 
 
25.
Mannila M.N., Lovely R.S., Kazmierczak S.C. i wsp. Elevated plasma fi brinogen gamma‘ concentration is associated with myocardial infarction: eff ects of variation in fibrinogen genes and environmental factors. J. Thromb. Haemost. 2007; 5: 766-773.
Google Scholar
 
 
26.
Leander K., Wiman B., Hallqvist J., Falk G., De Faire U. The G-455A polymorphism of the fi brinogen Bbeta-gene relates to plasma fi brinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women. J. Intern. Med. 2002; 252: 332-341.
Google Scholar
 
 
27.
Bots M.L., Elwood P.C., Salonen J.T. i wsp. Level of fi brinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J. Epidemiol. Community Health 2002; 56 Suppl 1: i14-8.
Google Scholar
 
 
28.
Mills J.D., Ariens R.A., Mansfi eld M.W., Grant P.J. Altered fi brin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation 2002; 106: 1938-1942.
Google Scholar
 
 
29.
Weng X., Cloutier G., Genest J. Jr. Contribution of the -455G/A polymorphism at the betafi brinogen gene to erythrocyte aggregation in patients with coronary artery disease. Thromb. Haemost. 1999; 82:1406- 1411.
Google Scholar
 
 
30.
Scarabin P.Y., Aillaud M.F., Amouyel P. i wsp. Associations of fi brinogen, factor VII and PAI-1 with baseline fi ndings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb. Haemost. 1998; 80: 749-756.
Google Scholar
 
 
31.
Boekholdt S.M., Bijsterveld N.R., Moons A.H., Levi M., Buller H.R., Peters R.J. Genetic variation in coagulation and fi brinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation 2001; 104: 3063-3068.
Google Scholar
 
 
32.
Koch W., Hoppmann P., Biele J., Mueller J.C., Schömig A., Kastrati A. Fibrinogen genes and myocardial infarction: a haplotype analysis. Arterioscler. Thromb. Vasc. Biol. 2008; 28: 758-763.
Google Scholar
 
 
33.
Choumerianou D.M., Maumus S., Skoumas J. et all. Polymorphisms associated with apolipoprotein B levels in Greek patients with familial hypercholesterolemia. Clin. Chem. Lab. Med. 2006; 44: 799- 806.
Google Scholar
 
 
34.
Zak I., Sarecka-Hujar B., Krauze J. Cigarette smoking, carrier state of A or G allele of 46A>G and 79C>G polymorphisms of beta2-adrenergic receptor gene, and the risk of coronary artery disease. Kardiol. Pol. 2008; 66: 380-386.
Google Scholar
 
 
35.
Zak I., Sarecka-Hujar B., Krauze J. Relationships between traditional risk factors and carrier-state of C allele of 1059G>C polymorphism in the C-reactive protein gene and the risk of coronary artery disease. Ann. Acad. Med. Siles. 2008; 62: 27- 33.
Google Scholar
 
 
36.
Zak I., Sarecka B., Krauze J. Synergistic eff ects between 561A >C and 98G> T polymorphisms of E-selectin gene and hypercholesterolemia in determining the susceptibility to coronary artery disease. Heart Vessels 2008; 23: 257-263.
Google Scholar
 
 
Share
Send by email
Indexes
 
Keywords index
Topics index
Authors index
eISSN:1734-025X
Journals System - logo


© 2006-2025 Journal hosting platform by Bentus
Scroll to top